メディカルプレスセンター QLifePro »外科

↧

Image may be NSFW.
Clik here to view.

小児患者における血液管理の一環としての非侵襲的・連続的ヘモグロビン測定がICU滞在期間の短縮と術後輸血の低減に結び付くことを示す新研究

December 15, 2020, 1:47 am

スイス・ヌーシャテル（ビジネスワイヤ） — マシモ（NASDAQ：MASI）は本日、2020年欧州麻酔学会議で最近報告されたサマリーの知見を発表しました。この研究では、マルマラ大学（トルコ、イスタンブール）のDr....

View Article

Image may be NSFW.
Clik here to view.

NEC Releases “WISE VISION Endoscopy” in Europe and Japan

January 11, 2021, 8:00 am

TOKYO NEC Corporation (NEC; TOKYO: 6701) today announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in...

View Article

Image may be NSFW.
Clik here to view.

Elixir Medical Announces First Patient Treated in BIOADAPTOR Randomized...

January 12, 2021, 8:00 pm

MILPITAS, Calif. Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that the first patient has been treated in the BIOADAPTOR randomized controlled trial...

View Article

Image may be NSFW.
Clik here to view.

Mike Durkin博士出任患者安全运动基金会董事会副主席

January 13, 2021, 10:38 am

加州尔湾 (美国商业资讯)–致力于到2030年实现零例可预防患者死亡目标的全球非营利性组织患者安全运动基金会(PSMF)已任命Mike Durkin, OBE, MBBS, FRCA, FRCP, DSc担任董事会副主席。Durkin博士将协助董事会主席Michael A.E. Ramsay, MD, FRCA就该组织创造更安全、更可靠医疗系统的目标提供指导和战略支持。...

View Article

Image may be NSFW.
Clik here to view.

Rapid Medical宣布任命James Romero为美洲区总裁

January 13, 2021, 10:16 pm

以色列约克南和佛罗里达州劳德代尔堡 (美国商业资讯)–专注于开发一流响应式可调节神经血管器械的公司Rapid Medical宣布James Romero出任公司美洲区总裁。Romero先生将负责公司治疗出血性和缺血性卒中患者的先进神经血管技术在美国、加拿大和拉丁美洲的增长和商业拓展。 Romero先生拥有在成长期和大型医疗器械公司长达20年的销售领导经验。在加入Rapid...

View Article

Image may be NSFW.
Clik here to view.

マイク・ダーキン医師が患者安全運動財団理事会の副会長に就任

January 15, 2021, 9:23 am

米カリフォルニア州アーバイン（ビジネスワイヤ） —...

View Article

Image may be NSFW.
Clik here to view.

Korea’s KAHF-Designated Hospitals Taking the Lead in Protecting Rights and...

January 19, 2021, 1:00 pm

SEOUL, South Korea Korea’s advanced medical technology attracts many foreigners to visit Korea for medical tourism and treatment each year. This press release features multimedia. View the full...

View Article

Image may be NSFW.
Clik here to view.

RapidAI Enhancing Stroke Care Across Australia

January 20, 2021, 9:00 pm

SAN MATEO, Calif. RapidAI, the leader in advanced imaging for stroke, today announced it now serves over 50 hospitals and teleradiology services in Australia. The Rapid stroke imaging platform is...

View Article

Image may be NSFW.
Clik here to view.

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn®...

January 28, 2021, 4:30 am

WOODSTOCK, Ga. Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

View Article

Image may be NSFW.
Clik here to view.

Takeda Completes Sale of TachoSil® to Corza Health

January 31, 2021, 2:00 pm

OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch (“TachoSil®”)...

View Article

Image may be NSFW.
Clik here to view.

SmartAssist搭載Impella 5.5による79%の生存率達成を示す大規模臨床研究の結果をSTS 2021で発表

February 2, 2021, 10:44 am

米マサチューセッツ州ダンバース（ビジネスワイヤ） — アビオメッド（NASDAQ: ABMD）は、米国とドイツの16施設でSmartAssist搭載Impella 5.5による治療を受けた患者356人を対象とした大規模な研究で、サポート離脱時の生存率が79%であったと発表しました。生存患者の大半は自己心機能を回復し、追加的な機械的補助や心臓移植を必要としませんでした。...

View Article

Image may be NSFW.
Clik here to view.

Professor Juan Marchal Believes Propanc Biopharma’s Proenzyme Therapy May...

February 14, 2021, 9:00 pm

MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...

View Article

Image may be NSFW.
Clik here to view.

新研究评估Masimo EMMA®二氧化碳分析仪在评估气管造口术儿童呼吸状态方面的能力

March 16, 2021, 9:49 am

瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天公布了《国际儿科学》(Pediatrics International)发表的一项观察性回顾性研究的结果。在该研究中，日本大阪妇幼医院的研究人员发现，Masimo...

View Article

Image may be NSFW.
Clik here to view.

LimFlow Receives Japan PMDA Approval for Clinical Study of Minimally-Invasive...

March 22, 2021, 7:30 pm

PARIS LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD),...

View Article

Image may be NSFW.
Clik here to view.

Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug

March 22, 2021, 10:00 pm

SANTA CLARA, Calif. Shape Memory Medical Inc. announced today that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug...

View Article